Solasta Ventures, Inc. (formerly known in the U.S. as Aju IB Investment) is a wholly-owned subsidiary of Aju IB Investment, a leading South Korean venture capital firm. We are committed to investing in innovative companies that advance the standard of care for diseases with unmet medical needs. Our team leverages deep scientific expertise and an extensive network to identify promising therapeutics and discovery platforms that have the potential to transform patients’ lives worldwide.
20
Total Investments
18
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Solasta Ventures
Recent Investments (20)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Late Vc | •••••• | Sep 2025 | |
| Series A | •••••• | Mar 2025 | |
| Venture Round | •••••• | Nov 2023 | |
| Series B | •••••• | Sep 2023 | |
| Series A | •••••• | Jun 2023 | |
|
|
Series B | •••••• | May 2023 |
|
|
Series B | •••••• | Jan 2023 |
|
|
Series C | •••••• | Jun 2022 |
|
|
Series A | •••••• | Jun 2022 |
|
|
Series B | •••••• | Feb 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.